Moreover, MMP-2 activity is required for the angiogenic switch during tumor development and has, together with MMP-9, been implicated in the regulation of expression and release of vascular endothelial growth factor (VEGF) (62–65). The gene discussed is VEGFA; the disease is neoplasm.